Apraglutide TFA (FE 203799 TFA), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum.
Apraglutide TFA is a synthetic peptide analog designed to mimic the biological activity of glucagon-like peptide-2 (GLP-2), a key gastrointestinal hormone involved in the regulation of intestinal growth, nutrient absorption, and mucosal barrier function. As a stabilized peptide, Apraglutide TFA demonstrates enhanced resistance to enzymatic degradation, making it highly suitable for in vitro and in vivo research applications that require sustained GLP-2 receptor activation. Its selectivity and prolonged activity profile have established it as a valuable tool for probing the physiological and molecular mechanisms underpinning intestinal adaptation, epithelial proliferation, and nutrient assimilation pathways. The compound's unique pharmacological attributes have attracted significant interest in the fields of gastrointestinal biology, peptide signaling, and metabolic research.
Peptide receptor pharmacology: Apraglutide TFA is extensively utilized in studies investigating GLP-2 receptor pharmacodynamics and downstream signaling cascades. By providing a stable and potent agonist for GLP-2R, it enables precise dissection of receptor-ligand interactions, G protein-coupled receptor (GPCR) activation, and the modulation of intracellular effectors such as cyclic AMP and kinases. Researchers leverage this compound to map tissue-specific responses to GLP-2 stimulation, facilitating a deeper understanding of receptor distribution, desensitization, and cross-talk with other signaling pathways.
Intestinal physiology research: The compound serves as a robust experimental agent for elucidating the role of GLP-2 in intestinal epithelial cell proliferation, mucosal regeneration, and barrier integrity. In preclinical models, Apraglutide TFA is applied to assess its effects on crypt cell mitogenesis, villus height, and tight junction protein expression. These studies are critical for advancing knowledge of gastrointestinal adaptive responses following injury, resection, or altered nutrient supply, and for modeling the molecular mechanisms that govern gut homeostasis.
Metabolic and nutrient absorption studies: Apraglutide TFA is instrumental in research focused on nutrient assimilation and metabolic adaptation. Its capacity to enhance intestinal surface area and modulate transporter expression makes it useful for analyzing the regulation of macronutrient absorption and the interplay between gut-derived peptides and systemic metabolic pathways. Experimental protocols frequently employ this peptide analog to quantify changes in glucose, amino acid, and lipid uptake, contributing valuable insights into the integration of gastrointestinal and whole-body energy balance.
Peptide stability and pharmacokinetic investigations: The TFA salt form of Apraglutide is particularly relevant in studies evaluating peptide stability, bioavailability, and degradation kinetics. Researchers utilize it as a reference compound to optimize peptide formulation, delivery strategies, and analytical methodologies. Its resistance to proteolytic cleavage allows for the assessment of extended peptide action in biological matrices, supporting the development of next-generation peptide therapeutics and delivery systems.
Peptide synthesis and analytical method development: Apraglutide TFA is also employed as a standard or reference in the optimization of peptide synthesis protocols and in the validation of analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry. Its well-characterized structure and physicochemical properties make it an ideal candidate for calibrating instrumentation, verifying peptide purity, and troubleshooting synthetic workflows in peptide chemistry laboratories. These applications are essential for ensuring the reproducibility and accuracy of peptide-based research and development efforts.
1. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More